Curewell Capital

Curewell Capital is a growth-oriented investment firm dedicated to building industry-leading healthcare companies. The firm partners with founders and management teams of companies that improve patient outcomes, create efficiencies, and foster innovation. Curewell Capital's proprietary GRO™ framework is tailored to each company to drive long-term value through growth and operational excellence.

The team brings decades of investment and operating experience at leading global healthcare companies across healthcare services, pharmaceutical services, medical devices, and healthcare technology. Curewell Capital's core principles include a passion for healthcare, building lasting relationships, striving for excellence, collaborative openness, alignment and teamwork, and a growth focus.

Curewell Capital's investment strategy is founded on three tenets: a seed funding model that allows the firm to de-risk the science and set companies up for success; genetic validation that increases the probability of success; and embedded Cure operators to drive the best day-to-day decision making in collaboration with founders. The firm is committed to working alongside entrepreneurs to bring cures to life and save lives by funding and working with those developing therapeutics for life-altering diseases.